Appetite Stimulation in Elderly Patients

Primary Recommendations

The American Geriatrics Society recommends prioritizing non-pharmacological interventions, including social dining, feeding assistance, and oral nutritional supplements, for elderly patients with appetite loss, reserving pharmacological appetite stimulants for specific clinical contexts 1, 2

Social dining interventions, such as placing patients at dining tables with others, can significantly improve intake and quality of life in elderly patients with appetite loss 5, 1
Feeding assistance strategies, including increased time spent by nursing staff on feeding assistance and emotional support during meals, can improve nutritional intake in elderly patients 1
Nutritional optimization, such as providing oral nutritional supplements when dietary intake falls to 50-75% of usual intake, can help meet nutritional requirements in elderly patients with appetite loss 3, 1

Mirtazapine is the first-line pharmacological agent for elderly patients with both appetite loss and depression, with a recommended dosing of 7.5 mg at bedtime, titrated to 15-30 mg based on response 1, 2, 6
Megestrol acetate is the most effective first-line pharmacological appetite stimulant for hospitalized or seriously ill elderly patients without depression, with a recommended dosing of 400-800 mg/day 1, 2, 6

Patients with dementia who lack concurrent depression should not be treated with appetite stimulants, as evidence shows no consistent benefit and potentially harmful side effects outweigh uncertain benefits 5, 1, 2
Patients with concurrent nausea/vomiting may be considered for olanzapine 5 mg/day, which addresses both symptoms 1

Regular reassessment (weeks 1, 2, 4, 8, 12) is necessary to evaluate benefit versus harm in elderly patients with appetite loss 1, 6
The European Society for Clinical Nutrition and Metabolism recommends screening for malnutrition using validated tools and implementing non-pharmacological interventions, such as social dining and feeding assistance, for elderly patients with appetite loss 6
The American College of Physicians recommends avoiding the routine use of appetite-stimulating agents in patients with dementia, as evidence shows no consistent benefit and potentially harmful side effects outweigh uncertain benefits 5, 2